Long-term outcome of mycophenolate mofetil rescue therapy for resistant acute allograft rejection in pediatric liver transplant recipients

Liver Transplantation

Volumn 14, Issue 9, 2008, Pages 1303-1308

  Aw, Marion Margaret ^a,b   Verma, Anita ^a   Rela, Mohamed ^a   Heaton, Nigel ^a   Mieli Vergani, Giorgina ^a   Dhawan, Anil ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; EDETATE CHROMIUM CR 51; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS;

ABDOMINAL PAIN; ACUTE GRAFT REJECTION; ADD ON THERAPY; ADOLESCENT; ARTICLE; CAUSE OF DEATH; CHILD; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DIARRHEA; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LIVER FUNCTION; LIVER GRAFT REJECTION; LYMPHOPROLIFERATIVE DISEASE; MALE; NEUTROPENIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; SINGLE DRUG DOSE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 51349105009     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21530     Document Type: Article

References (15)

1. Martin SR, Atkinson P, Anand R, Lindblad AS, and the SPLIT Research Group. Studies of Pediatric Liver Transplantation 2002; patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada. Pediatr Transplant 2004;8:273-283.
2. Kelly D, Jara P, Rodeck B, Lykavieris P, Burdelski M, Becker M, et al. Tacrolimus and steroids versus ciclosporin microemulsion, steroids and azathioprine in children undergoing liver transplantation: randomised European multicentre trial. Lancet 2004;346:1054-1061.
3. McAlister VC, Haddad E, Renouf E, Malthaner RA, Kjaer MS, Gluud LL. Cyclosporine versus tacrolimus as primary immunosuppression after liver transplantation: a meta-analysis. Am J Transplant 2006;6:1578-1585.
4. Chardot C, Nicoluzzi JE, Janssen M, Sokal E, Lerut J, Otte JB, Reding R. Use of mycophenolate mofetil as rescue therapy after paediatric liver transplantation. Transplantation 2001;71:224-229.
5. Pfitzmann R, Klupp J, Langrehr JM, Uhl M, Neuhaus R, Settmacher U, et al. Mycophenolate mofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients. Transplantation 2003;76:130-136.
6. Casas-Melley AT, Falkenstein KP, Flynn LM, Ziegler VL, Dunn SP. Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus. Pediatr Transplant 2004;8:362-366.
7. Afford SC, Hubscher S, Strain AJ, Adams DH, Neuberger JM. Apoptosis in the human liver during allograft rejection and end-stage liver disease. J Pathol 1995;176:373-380.
8. Cao S, Cox KL, Berquist W, Hayahi M, Concepcion W, Hammes GB, et al. Long-term outcomes in pediatric liver recipients: comparison between cyclosporine and tacrolimus. Pediatr Transplant 1999;3:22-26.
9. Jain A, Mazariegos G, Kashyap R, Green M, Gronsky C, Starzl TE, et al. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. Transplantation 2000;70:617-625.
10. McDiarmid SV. Renal function in pediatric liver transplant recipients. Kidney Int Suppl 1996;53:S77-S84.
11. Campbell KM, Yazigi N, Ryckman FC, Alonso M, Tiao G, Balistreri WF, et al. High prevalence of renal dysfunction in long-term survivors after pediatric liver transplantation. J Pediatr 2006;148:475-480.
12. Evans HM, McKiernan PJ, Kelly DA. Mycophenolate mofetil for renal dysfunction after paediatric liver transplantation. Transplantation 2005;79:1575-1580.
13. Aw MM, Samaroo B, Baker AJ, Verma A, Rela M, Heaton ND, et al. Calcineurin-inhibitor related nephrotoxicity - reversibility in paediatric liver transplant recipients. Transplantation 2001;72:746-749.
14. Samyn M, Cheeseman P, Bevis L, Taylor R, Samaroo B, Buxton-Thomas M, et al. Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl 2005;11:344-349.
15. Tredger JM, Brown NW, Adams J, Gonde CE, Dhawan A, Rela M, Heaton N. Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range. Liver Transpl 2004;10:492-502.